measuregroup/AID151830

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103169732_AID151830_PMID13678413_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103373500_AID151830_PMID13678413_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103374227_AID151830_PMID13678413_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID174510203_AID151830_PMID13678413_VALUE4
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5821
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	In vivo effective dose for antimalarial activity by peroral dose
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103374227 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103373500 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID174510203 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103169732
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID151830

Total number of triples: 13.